INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

110 hedge funds and large institutions have $84M invested in Insys Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 37 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.29M
Puts
$3.82M
Net Calls
Net Calls Change

Top Sellers

1 -$14.2M
2 -$11.4M
3 -$4.18M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.21M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$888K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$94K
52
$85K
53
$82K
54
$79K
55
$78K
56
$76K
57
$72K
58
$71K
59
$64K
60
$62K
61
$55K
62
$52K
63
$47K
64
$33K
65
$32K
66
$29K
67
$24.5K
68
$23K
69
$20K
70
$19K
71
$18K
72
$13K
73
$11K
74
$9K
75
$8K